Background Psoriasis is an immune‐mediated disease with either skin or joints
manifestations, or both, and it has a major impact on quality of life. Although there is …

To inform the WHO Global report on psoriasis, a new comprehensive worldwide systematic
review of the epidemiology of psoriasis was undertaken. The aim of this study was to …

Objective To systematically review and provide information on the incidence of psoriasis and
quantify global, regional, and country specific estimates of its prevalence. Design Systematic …

Background Interleukin-23 is thought to be critical to the pathogenesis of psoriasis. We
compared risankizumab (BI 655066), a humanized IgG1 monoclonal antibody that inhibits …

The worldwide incidence and prevalence of psoriasis is poorly understood. To better
understand this, we performed a systematic review of published population-based studies …

Background Psoriasis is a chronic inflammatory disorder associated with significant
morbidity and mortality. Up-to-date prevalence data on psoriasis provide the foundation for …

OBJECTIVE: To design a functional, patient-centered model of patient complexity with
practical applicability to analytic design and clinical practice. Existing literature on patient …

Importance Despite the growing literature on comorbidity risks in psoriasis, there remains a
critical knowledge gap on the degree to which objectively measured psoriasis severity may …

Background In this phase 2, randomized, double-blind, placebo-controlled, dose-ranging
study, we assessed the efficacy and safety of brodalumab (AMG 827), a human anti …

The reported prevalence of depression in psoriasis varies substantially. This study aims to
determine the prevalence and odds of depressive symptoms and clinical depression in …